2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1205063682 M.D.
Verify on CMS →

Esti Charlap, M.D.

Endocrinology, Diabetes & Metabolism Physician in New York, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
183
Medicare Part D claims · 50 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
0%
generic claims · 54% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Esti Charlap, M.D. filed 183 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in New York, New York, prescribing 0% generic.

183
Part D claims, 2024
0%
generic prescribing
Likely
board-certified (heuristic)
≥34th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Esti Charlap, M.D.

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1205063682), first enumerated 06/12/2009.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 183 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • State context

    State board disciplinary context

    New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Esti Charlap, M.D.'s individual license status. Verify directly with the state medical board.

    Source: NYSBPMC annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

Compare Charlap with other Endocrinology, Diabetes & Metabolism Physician providers

Same primary specialty, same federal CMS NPPES roster.

Also enrolled in New York

Other specialties in New York: Student in an Organized Health Care Education/Training Program (13,585) · Clinical Social Worker (6,421) · Social Worker (4,586) · Mental Health Counselor (3,807)

CMS NPPES provider registry desk

NPI 1205063682 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM

  • NPI-10 1205063682
  • ENUM-MID 2009
  • TAX-MID 8K Endocrinology, Diabetes
  • RX-LIGHT 183
  • BOOK-LIGHT 813 in New York
  • PHOTO-ENUM Farahnaz Joarder, M.D. · 2009

Esti Charlap, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

183 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

✓
Board certification likely (heuristic, not verified)

Esti Charlap, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Esti Charlap, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/12/2009

NPI 1205063682

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

8,078 US NPIs in this specialty

Medicare Part D claims

183 93% vs specialty avg

2024 prescription claims

Specialty avg: 2,739

Specialty distribution in New York

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers

New York providers
Student in an Organized Heal…8%Registered Nurse5.2%Clinical Social Worker4.9%Social Worker4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse4.3%Endocrinology, Diabetes & Me…0.1%
Largest specialties in New York (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

353 E 17TH ST
New York, NY 10003

Provider Details

NPI 1205063682
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 06/12/2009

Hospital and facility affiliations

Facilities where Esti Charlap, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Endocrinology Consultants, PC
Englewood, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Esti Charlap, M.D.. To verify Esti Charlap, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Esti Charlap, M.D. - brand share 54.0%
Endocrinology, Diabetes & Metabolism Physician average

54% brand-name claims vs 0% generic, on 183 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

183
Total Claims
$108K
Total Drug Cost
50
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
335.833
Total Day Supply
9,920
Brand vs Generic
54% brand / 0% generic
Brand Drug Cost
$107K

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
1.24
Gender Split
62% female / 38% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Esti Charlap, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Mounjaro
Tirzepatide
23
Jardiance
Empagliflozin
21
Metformin Hcl
21
Levothyroxine Sodium
17
Atorvastatin Calcium
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Esti Charlap, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider

Esti Charlap, M.D.'s 183 claims are below the specialty average of 2,739.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Charlap, both outside New York so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2009)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Charlap.

One of 813 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New York, 11 are shown on this page.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Esti Charlap, M.D.'s specialty? ▼
Esti Charlap, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in New York, New York. Credentials: M.D..
How much does Esti Charlap, M.D. prescribe under Medicare Part D? ▼
In 2024, Esti Charlap, M.D. wrote 183 Medicare Part D claims totaling $108K in drug costs for 50 beneficiaries.
Where is Esti Charlap, M.D. located? ▼
Esti Charlap, M.D. is located at 353 E 17TH ST, New York, NY, 10003. Phone: (973) 941-9206.
What is Esti Charlap, M.D.'s NPI number? ▼
Esti Charlap, M.D.'s National Provider Identifier (NPI) is 1205063682, issued on 06/12/2009.
Does Esti Charlap, M.D. prescribe more brand-name or generic drugs? ▼
Esti Charlap, M.D.'s prescribing is 54% brand-name and 0% generic drugs by claim count, with $107K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Esti Charlap, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Esti Charlap, M.D.'s most frequently prescribed drugs include Mounjaro, Jardiance, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Esti Charlap, M.D. accept Medicare? ▼
Esti Charlap, M.D. appears in CMS Medicare data with 183 Part D claims and 50 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Esti Charlap, M.D.'s credentials? ▼
Esti Charlap, M.D.'s NPI is 1205063682 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.